Century Therapeutics Inc
0.00 (0.0%)


Draw Mode:

Volume 0
Bid Price 2.85
Ask Price 3.50
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Century Therapeutics Inc IPSC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 3.46 04:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 3.40 - 14.00
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 3.46 USD

Century Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 204.73M 59.17M 12.84M $ 5.20M $ - -2.28 100.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 2.65M 3.20%

more financials information »

Century Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No IPSC Message Board. Create One! See More Posts on IPSC Message Board See More Message Board Posts

Historical IPSC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.823.823.403.55163,441-0.36-9.42%
1 Month4.505.33993.404.18202,123-1.04-23.11%
3 Months4.995.33993.404.46218,517-1.53-30.66%
6 Months10.1011.953.405.89160,811-6.64-65.74%
1 Year12.5314.003.407.58132,553-9.07-72.39%
3 Years19.5032.8993.4014.59147,304-16.04-82.26%
5 Years19.5032.8993.4014.59147,304-16.04-82.26%

Century Therapeutics Description

Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.